Chronic Kidney Disease Trial, Recruiting (NCT06343727)

Chronic Kidney Disease Trial, Recruiting NCT06343727 Sponsor: Seven Oaks Hospital Chronic Disease Innovation Centre Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06343727 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to give your consent to take part in the trial
You are male or female, aged 18 or older, and have chronic kidney disease (CKD)
You have been receiving regular in-center hemodialysis (kidney dialysis at a clinic) for more than 3 months
Your blood albumin level (a protein measured in your blood) is below 35 g/L, which may indicate low protein levels
You are not planning to change your type of dialysis or move away from Winnipeg during the 12-week study period

Who may not be able to join:

You have an allergy to eggs
You have previously had a kidney transplant
Your blood albumin level is 35 g/L or higher
You have a bowel or intestinal disease
You have or have had cancer
You are currently pregnant
You are currently receiving chemotherapy
You are unable to consume the treatment product used in the study
You have an allergy to any ingredients in the study treatment
You are planning to start a new exercise program during the trial period
You are unable to provide written consent to participate

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2046313834

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06343727

Sponsor: Seven Oaks Hospital Chronic Disease Innovation Centre

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 2046313834

More information: https://clinicaltrials.gov/study/NCT06343727

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to give your consent to take part in the trial
You are male or female, aged 18 or older, and have chronic kidney disease (CKD)
You have been receiving regular in-center hemodialysis (kidney dialysis at a clinic) for more than 3 months
Your blood albumin level (a protein measured in your blood) is below 35 g/L, which may indicate low protein levels
You are not planning to change your type of dialysis or move away from Winnipeg during the 12-week study period

Who may not be able to join:

You have an allergy to eggs
You have previously had a kidney transplant
Your blood albumin level is 35 g/L or higher
You have a bowel or intestinal disease
You have or have had cancer
You are currently pregnant
You are currently receiving chemotherapy
You are unable to consume the treatment product used in the study
You have an allergy to any ingredients in the study treatment
You are planning to start a new exercise program during the trial period
You are unable to provide written consent to participate

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Seven Oaks Hospital Chronic Disease Innovation Centre

Registry

ClinicalTrials.gov

Start date

25 July 2025

Est. completion

11 August 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Eligibility to randomization ratio; Recruitment rate; Follow up rate; Adherence to Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov